| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.42 | 3e-17 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.25 | 6e-14 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.28 | 4e-08 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-07 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-06 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.18 | 8e-05 |